(Reuters) – The U.S. Food and Drug Administration said on Monday it had revoked the emergency use authorization for four COVID-19 treatments, including those from Eli Lilly and Regeneron.
(This story has been corrected to say four treatments, not five, in the headline and paragraph 1)
(Reporting by Bhanvi Satija in Bengaluru; Editing by Krishna Chandra Eluri)
Brought to you by www.srnnews.com
